Actively Recruiting
Enhancing Prospective Thinking in Early Recovery (HOME)
Led by Indiana University · Updated on 2026-05-04
500
Participants Needed
1
Research Sites
180 weeks
Total Duration
On this page
Sponsors
I
Indiana University
Lead Sponsor
N
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to use a novel virtual reality intervention to test for efficacy in reducing alcohol use and increasing abstinence, with concomitant increases in future self-identification, future time perspective, and delay-of-reward, in early recovering alcohol use disorder (AUD) persons. The main question\[s\] this trial aims to answer are: Will the Virtual Reality (VR) intervention decrease the number of stimulant use days? Will the VR intervention produce longer abstinence periods during follow-up visits? Will the VR intervention increase alcohol abstinence rates? Will the VR intervention increase future self-identification? Will the VR intervention increase self-reported future time perspective? Will the VR intervention increase preference for delayed rewards in a laboratory delay discounting task on the study day? Will the VR intervention produce gains in the behavioral effects of future self-identification, future time perspective, and delayed rewards at the 30-day and 6-month follow-ups? Researchers will compare the experimental and control groups to see if there are differences in the results for the questions outlined above.
CONDITIONS
Official Title
Enhancing Prospective Thinking in Early Recovery (HOME)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Abstinent from alcohol for at least 14 days and less than or equal to 1 year
- Verbal commitment to recovery
- Receiving outpatient treatment
- Using psychotropic drugs for substance use disorder comorbidity
- Abstinent from drugs and alcohol for at least 24 hours at study visit
- Able to understand and speak English
You will not qualify if you...
- Having unstable medical disorders
- Habitual drug use
- Use of mu-opioid drugs
- Having smell or taste disorders
- Having unstable psychiatric conditions
- Having extravagant or elaborate face tattoos
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Indiana University School of Medicine - Goodman Hal
Indianapolis, Indiana, United States, 46202
Actively Recruiting
Research Team
S
Sarah Turo, BA
CONTACT
C
Colton Lind, BS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
BASIC_SCIENCE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here